Company · CIK 0001549595 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Nurix Therapeutics, Inc. · NRIX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 2, 7:42 pm EDT | Christine RingChief Legal Officer | 5,787 | $25.76 | $149,072 | 9,110 | −38.8% | 10b5-1 |
| Sep 2, 2026 MForm 4 → | Sep 2, 7:42 pm EDT | Christine RingChief Legal Officer | 5,787 | $8.72 | $50,463 | 14,897 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 5:19 pm EDT | Gwenn HansenChief Scientific Officer | 1,452 | $25.47 | $36,982 | 117,227 | −1.22% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 5:19 pm EDT | Gwenn HansenChief Scientific Officer | 1,452 | $1.86 | $2,701 | 118,679 | — | 10b5-1 |
| Aug 5, 2026 SForm 4 → | Aug 5, 6:59 pm EDT | Gwenn HansenChief Scientific Officer | 4,356 | $25.00 | $108,900 | 117,227 | −3.58% | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 5, 6:59 pm EDT | Gwenn HansenChief Scientific Officer | 4,356 | $1.86 | $8,102 | 121,583 | — | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 5, 6:39 am EDT | Gwenn HansenChief Scientific Officer | 4,111 | $24.36 | $100,142 | 117,227 | −3.39% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 4, 9:41 pm EDT | Hans van HouteChief Financial Officer | 4,761 | $24.36 | $115,989 | 40,166 | −10.6% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 3, 5:51 pm EDT | Christine RingChief Legal Officer | 16,589 | $23.05 | $382,358 | 9,110 | −64.6% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 3, 5:51 pm EDT | Christine RingChief Legal Officer | 5,787 | $8.72 | $50,463 | 25,699 | — | 10b5-1 |
| Jul 30, 2026 SForm 4 → | Jul 30, 5:58 pm EDT | Hans van HouteChief Financial Officer | 2,845 | $23.38 | $66,524 | 44,927 | −5.96% | |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:58 pm EDT | Hans van HouteChief Financial Officer | 10,180 | — | — | 47,772 | — | |
| Jul 30, 2026 SForm 4 → | Jul 30, 5:56 pm EDT | Christine RingChief Legal Officer | 3,847 | $23.38 | $89,954 | 19,912 | −16.2% | |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:56 pm EDT | Christine RingChief Legal Officer | 10,180 | — | — | 23,759 | — | |
| Jul 30, 2026 SForm 4 → | Jul 30, 5:50 pm EDT | Gwenn HansenChief Scientific Officer | 3,847 | $23.38 | $89,954 | 121,338 | −3.07% | |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:50 pm EDT | Gwenn HansenChief Scientific Officer | 10,180 | — | — | 125,185 | — | |
| Jul 2, 2026 SForm 4 → | Jul 2, 6:02 pm EDT | Christine RingChief Legal Officer | 11,008 | $23.56 | $259,366 | 13,579 | −44.8% | 10b5-1 |
| Jul 2, 2026 MForm 4 → | Jul 2, 6:02 pm EDT | Christine RingChief Legal Officer | 11,008 | $5.47 | $60,174 | 24,587 | — | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 25, 6:49 pm EDT | Gwenn HansenChief Scientific Officer | 5,394 | $20.00 | $107,880 | 115,005 | −4.48% | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 25, 6:38 pm EDT | Christine RingChief Legal Officer | 28,935 | $20.06 | $580,506 | 13,579 | −68.1% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 25, 6:38 pm EDT | Christine RingChief Legal Officer | 28,935 | $8.05 | $232,847 | 42,514 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 MForm 4 → | Sep 2, 7:42 pm EDT | Christine RingChief Legal Officer | 5,787 | — | — | 117,037 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 5:19 pm EDT | Gwenn HansenChief Scientific Officer | 1,452 | — | — | 60,858 | — | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 5, 6:59 pm EDT | Gwenn HansenChief Scientific Officer | 4,356 | — | — | 62,310 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 3, 5:51 pm EDT | Christine RingChief Legal Officer | 5,787 | — | — | 122,824 | — | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:58 pm EDT | Hans van HouteChief Financial Officer | 10,180 | — | — | 39,303 | — | |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:56 pm EDT | Christine RingChief Legal Officer | 10,180 | — | — | 39,303 | — | |
| Jul 30, 2026 MForm 4 → | Jul 30, 5:50 pm EDT | Gwenn HansenChief Scientific Officer | 10,180 | — | — | 39,303 | — | |
| Jul 2, 2026 MForm 4 → | Jul 2, 6:02 pm EDT | Christine RingChief Legal Officer | 11,008 | — | — | 128,611 | — | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 25, 6:38 pm EDT | Christine RingChief Legal Officer | 28,935 | — | — | 134,398 | — | 10b5-1 |